Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invigor Medical vs yourEra

By GLP-1 ScorecardUpdated

Invigor Medical
Site position #10

Higher grade

yourEra
Site position #7

Lower grade

Score comparison

Invigor Medical has the higher recorded score — 86.1/100 to 83.8/100.

Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established pharmacy operator with steady mid-market pricing and a broad catalog.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueInvigor Medical +2
84
82
Dose & formulationInvigor Medical +2
84
82
Clinical oversightInvigor Medical +3
88
85
Labs & monitoringInvigor Medical +1
86
85
FulfillmentInvigor Medical +2
88
86
Contract termsInvigor Medical +5
90
85
Invigor Medical · top baryourEra · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricInvigor MedicalyourEra
WeighScore86.1/10083.8/100
GradeBB
Site position#10#7
Semaglutide$199/mo$89/mo (new-patient offer; confirm refill terms)
Tirzepatide$339/mo$129/mo (new-patient offer; confirm refill terms)
CoverageNot disclosed50-state clinician network; treatment availability varies by state
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Invigor Medical

Site position #10 · B

Strengths

  • Mid-market pricing on both molecules
  • Long-running operator

What to consider

  • No explicit states list
  • Compounded only
yourEra

Site position #7 · B

Strengths

  • Public new-patient month-to-month prices; advertised same price across doses while active
  • Evaluation, medication, injection supplies, dose management and shipping advertised together
  • Terms name Thryv Telehealth by Lavin, P.C. and three potential dispensing pharmacies
  • Free requested live visit; policy promises full refund if canceled before dispatch

What to consider

  • Compounded formulations are not FDA-approved branded products
  • Homepage price-continuation promise and terms allowing future refill price changes need reconciliation
  • Optimum coaching, nutrition, at-home labs and wearables are coming soon, with no confirmed price or launch date
  • Assessment usually asynchronous; prescription issuance triggers billing, and treatment availability varies by state

Featured provider

yourEra

yourEra scores 83.8/100 (B). Compounded semaglutide and tirzepatide injections advertised at $89/$129 monthly for new patients, with a named medical practice and three possible pharmacies; confirm the continuing price because homepage and terms differ.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard